Cornercap Investment Counsel Inc Ikena Oncology, Inc. Transaction History

Cornercap Investment Counsel Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	SELL	$1.33 - $4.4 $1,445 - $4,782	-1,087 Reduced 2.92%	36,157 $71,000
Q3 2023 Nov 13, 2023	SELL	$4.09 - $6.43 $4,515 - $7,098	-1,104 Reduced 2.88%	37,244 $161,000
Q2 2023 Aug 11, 2023	SELL	$3.5 - $7.31 $3,895 - $8,136	-1,113 Reduced 2.82%	38,348 $251,000
Q1 2023 May 11, 2023	BUY	$2.62 - $4.97 $26,189 - $49,680	9,996 Added 33.92%	39,461 $136,000
Q3 2022 Nov 14, 2022	BUY	$3.46 - $6.0 $44,388 - $76,974	12,829 Added 77.12%	29,465 $105,000
Q2 2022 Aug 15, 2022	BUY	$3.23 - $7.4 $53,734 - $123,106	16,636 New	16,636 $74,000

30.9M

Ticker IKNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,257,500
Market Cap $54.4M
Description
Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Cornercap Investment Counsel Inc with notifications on news.